OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD274 promotes cell cycle entry of leukemia-initiating cells through JNK/Cyclin D2 signaling
Xia Fang, Chiqi Chen, Fangzhen Xia, et al.
Journal of Hematology & Oncology (2016) Vol. 9, Iss. 1
Open Access | Times Cited: 25

Showing 25 citing articles:

Macrophage targeting in cancer
Martha Lopez‐Yrigoyen, Luca Cassetta, Jeffrey W. Pollard
Annals of the New York Academy of Sciences (2020) Vol. 1499, Iss. 1, pp. 18-41
Open Access | Times Cited: 181

Cancer Stem Cells and Targeting Strategies
Luisa Barbato, Marco Bocchetti, Anna Di Biase, et al.
Cells (2019) Vol. 8, Iss. 8, pp. 926-926
Open Access | Times Cited: 172

PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways
Wei Fang, Tong Zhang, Shu-Chou Deng, et al.
Cancer Letters (2019) Vol. 450, pp. 1-13
Closed Access | Times Cited: 155

Is CD47 an innate immune checkpoint for tumor evasion?
Xiaojuan Liu, Hyunwoo Kwon, Zihai Li, et al.
Journal of Hematology & Oncology (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 156

Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
Xingcheng Yang, Ling Ma, Xiaoying Zhang, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 56

Clinical applications of PD-L1 bioassays for cancer immunotherapy
Delong Liu, Shuhang Wang, Wendy Bindeman
Journal of Hematology & Oncology (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 76

The expression and clinical relevance of PD-1, PD-L1, and TP63 in patients with diffuse large B-cell lymphoma
Fang Xia, Bing Xiu, Zhi-Zhang Yang, et al.
Medicine (2017) Vol. 96, Iss. 15, pp. e6398-e6398
Open Access | Times Cited: 55

JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/β-catenin/CCND1 signaling
Yaping Zhang, Fangzhen Xia, Xiaoye Liu, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 5, pp. 1737-1751
Open Access | Times Cited: 49

Immune checkpoints regulate acute myeloid leukemia stem cells
C. Bachmann, Adrian F. Ochsenbein
Leukemia (2025)
Open Access

Progress of research on PD-1/PD-L1 in leukemia
Huizhen Cao, Tianyu Wu, Xue Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12

PD‐L1 regulates tumor proliferation and T‐cell function in NF2‐associated meningiomas
Ying Wang, Chao Zhang, Minjun Yan, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 6
Open Access | Times Cited: 3

Injury activated alveolar progenitors (IAAPs): the underdog of lung repair
Chong Lei, Negah Ahmadvand, Afshin Noori, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 6
Open Access | Times Cited: 8

A Cyclin D2-derived peptide acts on specific cell cycle phases by activating ERK1/2 to cause the death of breast cancer cells
Lilian C. Russo, Christiane B. de Araujo, Leo Kei Iwai, et al.
Journal of Proteomics (2016) Vol. 151, pp. 24-32
Closed Access | Times Cited: 25

PD‑L1 promotes head and neck squamous cell carcinoma cell growth through mTOR signaling
Anyuan Zheng, Fen Li, Fuhai Chen, et al.
Oncology Reports (2019)
Open Access | Times Cited: 25

An antitumor peptide RS17‐targeted CD47, design, synthesis, and antitumor activity
Xinmin Wang, Ying Wang, Jialiang Hu, et al.
Cancer Medicine (2021) Vol. 10, Iss. 6, pp. 2125-2136
Open Access | Times Cited: 16

TCF-1+ PD-1+ CD8+T cells are associated with the response to PD-1 blockade in non-small cell lung cancer patients
Fang Xia, Gang Wu, Jing Hua, et al.
Journal of Cancer Research and Clinical Oncology (2021) Vol. 148, Iss. 10, pp. 2653-2660
Closed Access | Times Cited: 10

Research progress on the intrinsic non‑immune function of PD‑L1 in tumors (Review)
Jiao Deng, Wei Jiang, Liang Liu, et al.
Oncology Letters (2022) Vol. 25, Iss. 1
Open Access | Times Cited: 6

Down regulation of miR-143 promotes radiation – Induced thymic lymphoma by targeting B7H1
Hainan Zhao, Ying Cheng, Suhe Dong, et al.
Toxicology Letters (2017) Vol. 280, pp. 116-124
Closed Access | Times Cited: 8

Downregulating LKB1 in bone marrow mesenchymal stem cells could inhibit CD4+ T cell proliferation via the PD-1/PD-L1 signaling pathway
Yaqin Zhang, Jingyi Ren, Zhongxian Liao, et al.
Immunobiology (2024) Vol. 229, Iss. 6, pp. 152856-152856
Open Access

Prenatal Metal Exposure Alters the Placental Proteome in a Sex-Dependent Manner in Extremely Low Gestational Age Newborns: Links to Gestational Age
Anastasia N. Freedman, Kyle R. Roell, Eiona Engwall, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14977-14977
Open Access | Times Cited: 1

The Prognostic Significance of the BIN1 and CCND2 Gene in Adult Patients with Acute Myeloid Leukemia
Xinwen Zhang, Hao Xiong, Jialin Duan, et al.
Indian Journal of Hematology and Blood Transfusion (2021) Vol. 38, Iss. 3, pp. 481-491
Open Access | Times Cited: 2

TCF-1+ PD-1+ CD8+T Cells Are Associated With The Response To PD-1 Blockade In Non-Small Cell Lung Cancer Patients
Xia Fang, Gang Wu, Jing Hua, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 2

Page 1

Scroll to top